Thanks PViewsMelters comments highlight a couple of the key risks for this company. Nevertheless, discordance within the board is just as problematic. I'll be looking for any clues for what this will mean for the Wingate holding.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%